In certain strains of Staphylococcus aureus, a concentration of erythromycin between 10-8 and 10-7 M can induce resistance to concentrations of this drug as high as 10-4 M. In one such strain studied, S. aureus (1206), N6-dimethyladenine is not normally present in 23S rRNA; however, a compound presumptively identified (on the basis of paper chromatography in three different solvents) as N6-dimethyladenine appears in the 23S rRNA of growing cells that have been incubated in a medium containing 10-7 M erythromycin. It has been shown previously that the induction of the erythromycinresistant phenotype that occurs under these conditions requires 10-8-10-7 M erythromycin for maximal expression within 1 hr and that induction results in modified 50S ribosomal subunits, which are then unable to bind erythromycin or lincomycin. Methylated adenine is also found in the 16S rRNA from the strain of S. aureus studied; however, in contrast to the situation with 23S rRNA, the amount in 16S rRNA is not affected by erythromycin. These findings provide the first example of a correlation between the methylation of rRNA and altered ribosomal function.
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In certain strains of Staphylococcus aureus, erythromycin can function as an inducer of resistance to 3 of 8 classes of inhibitors known to act on the 50S ribosomal subunit; these include the macrolides, lincosamides, and streptogramin B families of antibiotics. Some of the properties of these inducible strains and of derived constitutive mutants have been described, together with references to the work of others (1, 2) . 50S ribosomal subunits obtained from induced-and constitutively-resistant cells show a decreased ability to bind erythromycin and lincomycin, and the possibility of enzymatic inactivation of these drugs was rigorously excluded. Previous studies suggested that erythromycin can induce a modification in the structure of the ribosome, and that synthesis of protein and RNA, but not of DNA, was required for this modification to be expressed. We therefore compared the structural components of sensitive and resistant ribosomes in order to localize the putative structural modification(s) induced by erythromycin. We found that a compound, tentatively identified as N6-dimethyladenine, was present in 23S rRNA obtained from induced-and constitutively-resistant cells, but not in 23S rRNA obtained from sensitive, uniniduced cells.
MATERIALS AND METHODS Bacterial strains and medium
The properties of S. aureus (strain 1206+), inducibly resistant to erythromycin, and of a derived constitutivelyresistant mutant have been described (1, 2 
RESULTS
Previous studies of altered ribosomes obtained from antibioticresistant cells have centered on the ribosomal proteins. In the case of the 30S ribosomal subunit, altered proteins that can confer resistance to streptomycin and to spectinomycin have been identified by Ozaki et al. (6) and by Bollen et al. (7), respectively. In the case of the 50S ribosomal subunit, Otaka et al. (8) reported an alteration of 50S ribosomal protein obtained from erythromycin-resistant Escherichia coli. A search (by electrophoresis in acrylamide gel) for altered ribosomal proteins in our strain of erythromycin-resistant S. aureus failed to reveal consistent qualitative differences in proteins obtained from induced, uninduced, or constitutivelyresistant cells. As our next choice, we decided to examine possible differences in rRNA. We first looked for differences in methylation because this modification of rRNA is a wellknown one, and we assumed from the rapid appearance of induced cells that some modification of rRNA, rather than the synthesis of a new species with altered primary sequence, was responsible for the induced resistance. We therefore set up two parallel cultures: in one, induced with erythromycin, the growth medium was supplemented with [methyl- 'H]methionine; in the other culture, uninduced, the growth medium was supplemented with [methyl-"4C ]methionine.
The bacteria were collected and ribosomes were prepared. 16S and 23S rRNAs were obtained from the 30S and 50S ribosomal subunits. The respective 16S and 235 rRNAs, labeled with 'H and 'IC, were mixed and depurinated with acid as described above.
Because the 50S subunit is involved in erythromycin binding, we examined the methylated purine fraction obtained from 23S rRNA; the results are shown in Figs. 1 and 2. A peak of radioactivity in the methylated-adenine However, this methylated-adenine peak was present in the uninduced control as well. In both the 23S and 16S rRNA, no qualitative differences were noted in the methylated guanines.
Methylated pyrimidine monophosphates and methylated ribose were also fractionated. Three main fractions could be distinguished. These were, in accordance with Iwanami and Brown (4, 5) , N4-methyl CMP, 2'-O-methylribose phosphate, and the methylated-uridylate fractions. No differences between induced, uninduced, or constitutive cells were noted with respect to these fractions. The pyrimidines were, therefore, not examined further.
The methylated-adenine fractions from each column step were concentrated and further fractionated by paper chromatography in three solvents. The results of fractionation with solvent B, shown in Figs. 5 and 6, suggest that N6- dimethyladenine is the predominant component present in both the 16S and 23S rRNA. In 23S rRNA, the peak is skewed, suggesting the presence of an additional component that runs slower than dimethyladenine.
The pooled methylated-adenine fractions from 23S rRNA were also fractionated in two other solvents. Chromatography with solvent A (Fig. 7) shows that the main radioactive compound cofracttonates with the dimethyladenine reference standard. A significant portion of the radioactivity, however, forms a peak (fraction 8) with an Rf corresponding to that of adenine.
Chromatography with solvent C (Fig. 8) again reveals that the main component cofractionates with the dimethyladenine reference standard. In this solvent also, a significant portion of the radioactivity forms a peak at fraction 12 which corresponds in Rf to adenine. The basis for this apparent incorporation of [3H]methyl from methionine into adenine (or into some compound indistinguishable from adenine in two solvents) was not further examined. Material for these latter two fractionations was obtained in a different experiment from that shown in Fig. 1 .
Finally, the identification of dimethyladenine in the 16S rRNA was established by chromatographic experiments similar to those described above (data not shown). Whereas this base appears to be present in both 16S and 23S rRNA, it is present in 23S rRNA only as a consequence of induction with erythromycin or mutation to constitutive expression of erythromycin resistance.
DISCUSSION
The presence of methylated bases in rRNA from various sources has been reviewed by Starr and Sells (9) , and sequences in the rRNA of E. coli that contain some of these bases have been characterized by Fellner (10) . Prior to this paper, no correlation of the methylation of rRNA with function has been reported; the present studies of erythromycin resistance in S. aureus provide the first example of such a correlation. It is not clear, however, whether the methylation that we have observed is the cause or the result of resistance.
It was previously shown that inhibition of RNA and protein synthesis, but not of DNA synthesis, could inhibit induction of the erythromycin-resistant phenotype (2) . We can propose three models to explain these observations: (a) mRNA and protein synthesis are required for synthesis of the putative adenine-methylating enzyme(s); (b) antibiotics may interfere with the synthesis of ribosomal proteins or RNA required for ribosome assembly; or (c) the antibioticribosome complex may provide a poor substrate for methylating enzymes. Alternatively, the erythromycin-ribosome complex may be the substrate required for a methylating enzyme that is constitutively synthesized. According to this model, erythromycin would act as inducer by altering ribosomal conformation so as to make the ribosome a suitable substrate for the putative methylating enzymes. Constitutive resistance could then be explained by a mutational change of a structural component of the ribosome such that erythromycin is not required for the ribosome to assume the methyl- (Fig. 1) , containing the methylated adenines, were lyophilized and further fractionated by paper chromatography with Solvent B (together with reference standards). The chromatogram was cut into 1-cm-wide strips, which were eluted with water, and the eluate was tested for UV absorption and for radioactivity.
(Right) FIG. 6 . Fractionation of methylated adenines from 16S rRNA by paper chromatography. The procedure was the same as in Fig. 5. atable conformation. One possible way of distinguishing between these alternative models would be to study in vitro methylation of ribosomal RNA with a homogeneous enzyme preparation.
The process of induction of the erythromycin-resistant phenotype may be more complex than described above since (a) a trace of a compound that cofractionates with N8-methyladenine is present in 23S rRNA from induced cells (Fig. 5) , and (b) the presumptive N6-dimethyladenine peak in the same figure appears skewed, and may contain additional unidentified components. The presence of N6-dimethyladenine in both 16S and 23S rRNA would suggest that at least two different enzymes, each specific for adenine, may be present-the 16S-specific enzyme constitutive, and the 23S-specific enzyme inducible.
We can speculate on the role of methyl groups in the activity of antibiotics. According to one model, N-methylation of a specific adenine residue inhibits hydrogen bonding between the antibiotic and the 50S ribosomal subunit. Some quantitative estimate of the ability of N6-methylated adenines to participate in hydrogen-bonding interactions may be obtained from comparative studies of the thermal stability of double-stranded polyribonucleotides containing uridylate residues in one strand and methylated adenylate residues in the other. Griffin et al. (11) reported that poly(N6-methyladenylate) plus poly(U) had a Tm of 15°C, while the Tm of poly(N8-dimethyladenylate) plus poly(U) was too low to measure because of the very low affinity between these two polynucleotides. In contrast, Doty et al. (12) observed that the Tm of poly(A) plus poly(U) was 61°C. From these studies, we infer that the N8-methyl group may weaken the participation of adenine in hydrogen-bond formation. Consistent with the importance of the role of the 6-amino group in erythromycin binding is the observation of Mao and Putterman (13) that treatment of 50S ribosomal subunits with formaldehyde greatly reduced the ability of these subunits to bind erythromycin. It is also of interest that the presence of dimethyladenylate residues in the 16S rRNA of E. coli was found by Fellner (10) to markedly alter the reactivity of oligonucleotides containing these groups in enzymatic and alkaline hydrolysis reactions, and he postulated that this effect might be mediated by (unspecified) alterations in configuration and/or charge properties of neighboring bases.
N-methyl groups present in the antibiotics also play an important functional role in their activity. N-demethylation of erythromycin and lincomycin greatly reduces their inhibitory activity. The desosamine moiety of erythromycin contains an N-dimethylamino group, and removal of one of these methyl groups reduces the antimicrobial potency to 5% that of the parent compound (P. H. Jones, personal communication). Lincomycin contains a single N-methylprolyl moiety, and removal of this group reduces activity to 6% of the parent compound (14) . With respect to antibiotic structure, it is apparent that the effect of methylation on putative hydrogen-bond formation is such that optimum binding to the 50S subunit is a function of the presence of N-methylation. E. coli 5OS ribosomal subunits, as we have shown previously (15) , have a lower affinity for lincomycin than do 50S subunits obtained from Bacillus stearothermophilus, a grampositive organism. The 23S rRNA from E. coli does indeed contain methylated adenines, as shown in the structural studies of Fellner (10) , although dimethyladenine was only found in 16S rRNA from E. coli. It would be useful to have further data on rRNA structure and the extent to which the methylated adenines in 23S rRNA from E. coli and S. aureus serve While the present studies provide a significant qualitative difference between 23S rRNA from induced and uninduced cells, the precise number of modified residues per RNA molecule remains to be determined. An approximation can be made from Fig. 1 . We note approximately equal areas under the curves for methylated forms of guanine (fractions 18-26) and methylated forms of adenine (fractions 50-74). This would suggest equal amounts of these two species. If we assume that the yields of adenines and guanines are derived from integral molar amounts present, and that no significant losses occurred during preparation or separation, we can estimate an average value of at least two methylated adenine residues per 50S subunit. Fellner's data (10) suggest that this lower limit may be twice as large, in view of the occurrence of at least 2 mol of each of the methylated purine species per mol of 23S rRNA. The presence of more than one methylated form of adenine in the 23S rRNA from induced cells would be useful in explaining the classes of variable constitutivity that we describe elsewhere (2) .
In other studies (2), mutants of S. aureus 1206 were selected that were coresistant to the three classes of antibiotics cited. In the absence of genetic mapping data, this designation of "constitutivity" was a presumptive one. In our present studies, the induced and constitutive strains were qualitatively indistinguishable with respect to methylation, although some quantitative differences may exist. These results provide independent support for the contention that the so-called "constitutive" strains, described above, are altered only with respect to regulation of resistance-the mechanism of which is similar in both strains. Although these studies provide some data concerning the qualitative nature of altered rRNA, it has not been rigorously demonstrated whether the RNA in the intact ribosome is methylated, or whether methylation occurs during synthesis and/or assembly of new ribosomes. Neither has methylation been shown to be the actual cause of resistance to erythromycin.
